Long-Term Therapy With Bevacizumab in a Patient With Glanzmann’s Thrombasthenia and Recurrent Digestive Bleeding due to Gastrointestinal Angiodysplastic Lesions
Raphaël Marlu(Université Grenoble Alpes), Bruno Bonaz(Inserm), Justine Barthelon(Université Grenoble Alpes), Aurora Tatu(Université Grenoble Alpes), Gilles Pernod(Université Grenoble Alpes), Aurélie Durand(Centre National de la Recherche Scientifique), Victoire Granger(Canadian Partnership Against Cancer), Benoît Polack(Université Grenoble Alpes), Christian Barro(Brigham and Women's Hospital)
Cited by 20
Related Papers
Worldwide Prevalence and Burden of Functional Gastrointestinal Disorders, Results of Rome Foundation Global Study
|Gastroenterology|2020|2.1k
Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer’s disease
|Nature Medicine|2019|948
Non-Celiac Gluten Sensitivity: The New Frontier of Gluten Related Disorders
|Nutrients|2013|493
Five-Year Outcomes of FOLFIRINOX vs Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
|JAMA Oncology|2022|322